APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mesenchymal Stem Cells

Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.

Selected research

Industry Growth & Trends

Global Mesenchymal Stem Cells Industry Growth and Trends Forecast to 2032

2 January 2026100 pages

Choose your research edition.

Industry ResearchMesenchymal Stem Cells Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Mesenchymal Stem Cells Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Mesenchymal Stem Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mesenchymal Stem Cells Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Mesenchymal Stem Cells Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.

According to APO Research, the global Mesenchymal Stem Cells market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Mesenchymal Stem Cells market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Mesenchymal Stem Cells market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mesenchymal Stem Cells market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mesenchymal Stem Cells.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Mesenchymal Stem Cells market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Mesenchymal Stem Cells Market by Company

Lonza

Thermo Fisher

Bio-Techne

ATCC

MilliporeSigma

PromoCell GmbH

Genlantis

Celprogen

Cell Applications

Cyagen Biosciences

Axol Bioscience

Mesenchymal Stem Cells Segment by Type

Human MSC

Mouse MSC

Rat MSC

Others

Mesenchymal Stem Cells Segment by Application

Research Institute

Hospital

Others

Mesenchymal Stem Cells Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesenchymal Stem Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mesenchymal Stem Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesenchymal Stem Cells.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Mesenchymal Stem Cells companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Mesenchymal Stem Cells Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Mesenchymal Stem Cells Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Mesenchymal Stem Cells Market Share by Region (2021-2026) Table 4. Global Mesenchymal Stem Cells Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Mesenchymal Stem Cells Market Share by Region (2027-2032) Table 6. Global Mesenchymal Stem Cells Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Mesenchymal Stem Cells Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Mesenchymal Stem Cells Market Size Share by Type (2021-2026) Table 9. Global Mesenchymal Stem Cells Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Mesenchymal Stem Cells Market Size Share Forecasted by Type (2027-2032) Table 11. North America Mesenchymal Stem Cells Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Mesenchymal Stem Cells Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Mesenchymal Stem Cells Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Mesenchymal Stem Cells Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Mesenchymal Stem Cells Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Mesenchymal Stem Cells Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Mesenchymal Stem Cells Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Mesenchymal Stem Cells Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Mesenchymal Stem Cells Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Mesenchymal Stem Cells Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Mesenchymal Stem Cells Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Mesenchymal Stem Cells Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Mesenchymal Stem Cells Market Size Share by Application (2021-2026) Table 24. Global Mesenchymal Stem Cells Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Mesenchymal Stem Cells Market Size Share Forecasted by Application (2027-2032) Table 26. North America Mesenchymal Stem Cells Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Mesenchymal Stem Cells Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Mesenchymal Stem Cells Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Mesenchymal Stem Cells Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Mesenchymal Stem Cells Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Mesenchymal Stem Cells Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Mesenchymal Stem Cells Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Mesenchymal Stem Cells Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Mesenchymal Stem Cells Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Mesenchymal Stem Cells Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Mesenchymal Stem Cells Industry Trends Table 37. Mesenchymal Stem Cells Industry Drivers Table 38. Mesenchymal Stem Cells Industry Opportunities and Challenges Table 39. Mesenchymal Stem Cells Industry Restraints Table 40. Global Mesenchymal Stem Cells Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Mesenchymal Stem Cells Revenue Market Share by Company (2021-2026) Table 42. Global Mesenchymal Stem Cells Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Mesenchymal Stem Cells Key Company Headquarters & Area Served Table 44. Global Mesenchymal Stem Cells Company, Product Type & Application Table 45. Global Mesenchymal Stem Cells Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Mesenchymal Stem Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Lonza Company Information Table 49. Lonza Business Overview Table 50. Lonza Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Lonza Mesenchymal Stem Cells Product Portfolio Table 52. Lonza Recent Development Table 53. Thermo Fisher Company Information Table 54. Thermo Fisher Business Overview Table 55. Thermo Fisher Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Thermo Fisher Mesenchymal Stem Cells Product Portfolio Table 57. Thermo Fisher Recent Development Table 58. Bio-Techne Company Information Table 59. Bio-Techne Business Overview Table 60. Bio-Techne Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Bio-Techne Mesenchymal Stem Cells Product Portfolio Table 62. Bio-Techne Recent Development Table 63. ATCC Company Information Table 64. ATCC Business Overview Table 65. ATCC Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. ATCC Mesenchymal Stem Cells Product Portfolio Table 67. ATCC Recent Development Table 68. MilliporeSigma Company Information Table 69. MilliporeSigma Business Overview Table 70. MilliporeSigma Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. MilliporeSigma Mesenchymal Stem Cells Product Portfolio Table 72. MilliporeSigma Recent Development Table 73. PromoCell GmbH Company Information Table 74. PromoCell GmbH Business Overview Table 75. PromoCell GmbH Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. PromoCell GmbH Mesenchymal Stem Cells Product Portfolio Table 77. PromoCell GmbH Recent Development Table 78. Genlantis Company Information Table 79. Genlantis Business Overview Table 80. Genlantis Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Genlantis Mesenchymal Stem Cells Product Portfolio Table 82. Genlantis Recent Development Table 83. Celprogen Company Information Table 84. Celprogen Business Overview Table 85. Celprogen Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Celprogen Mesenchymal Stem Cells Product Portfolio Table 87. Celprogen Recent Development Table 88. Cell Applications Company Information Table 89. Cell Applications Business Overview Table 90. Cell Applications Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Cell Applications Mesenchymal Stem Cells Product Portfolio Table 92. Cell Applications Recent Development Table 93. Cyagen Biosciences Company Information Table 94. Cyagen Biosciences Business Overview Table 95. Cyagen Biosciences Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Cyagen Biosciences Mesenchymal Stem Cells Product Portfolio Table 97. Cyagen Biosciences Recent Development Table 98. Axol Bioscience Company Information Table 99. Axol Bioscience Business Overview Table 100. Axol Bioscience Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Axol Bioscience Mesenchymal Stem Cells Product Portfolio Table 102. Axol Bioscience Recent Development Table 103. North America Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Mesenchymal Stem Cells Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Mesenchymal Stem Cells Market Share by Country (2021-2026) Table 106. North America Mesenchymal Stem Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Mesenchymal Stem Cells Market Share Forecast by Country (2027-2032) Table 108. Europe Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Europe Mesenchymal Stem Cells Market Size by Country (2021-2026) & (US$ Million) Table 110. Europe Mesenchymal Stem Cells Market Share by Country (2021-2026) Table 111. Europe Mesenchymal Stem Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Europe Mesenchymal Stem Cells Market Share Forecast by Country (2027-2032) Table 113. Asia-Pacific Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Asia-Pacific Mesenchymal Stem Cells Market Size by Country (2021-2026) & (US$ Million) Table 115. Asia-Pacific Mesenchymal Stem Cells Market Share by Country (2021-2026) Table 116. Asia-Pacific Mesenchymal Stem Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Asia-Pacific Mesenchymal Stem Cells Market Share Forecast by Country (2027-2032) Table 118. Latin America Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Latin America Mesenchymal Stem Cells Market Size by Country (2021-2026) & (US$ Million) Table 120. Latin America Mesenchymal Stem Cells Market Share by Country (2021-2026) Table 121. Latin America Mesenchymal Stem Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Latin America Mesenchymal Stem Cells Market Share Forecast by Country (2027-2032) Table 123. Middle East & Africa Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2021-2026) & (US$ Million) Table 125. Middle East & Africa Mesenchymal Stem Cells Market Share by Country (2021-2026) Table 126. Middle East & Africa Mesenchymal Stem Cells Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Middle East & Africa Mesenchymal Stem Cells Market Share Forecast by Country (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Mesenchymal Stem Cells Product Image Figure 3. Global Mesenchymal Stem Cells Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 5. Global Mesenchymal Stem Cells Market Share by Region: 2025 VS 2032 Figure 6. Global Mesenchymal Stem Cells Market Share by Region (2021-2032) Figure 7. North America Mesenchymal Stem Cells Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Mesenchymal Stem Cells Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Mesenchymal Stem Cells Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Mesenchymal Stem Cells Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Mesenchymal Stem Cells Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Human MSC Image Figure 13. Global Human MSC Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Mouse MSC Image Figure 15. Global Mouse MSC Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Rat MSC Image Figure 17. Global Rat MSC Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Mesenchymal Stem Cells Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Mesenchymal Stem Cells Market Share by Type 2025 VS 2032 Figure 22. North America Mesenchymal Stem Cells Market Size Share by Type (2021-2032) Figure 23. Europe Mesenchymal Stem Cells Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Mesenchymal Stem Cells Market Size Share by Type (2021-2032) Figure 25. Latin America Mesenchymal Stem Cells Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Mesenchymal Stem Cells Market Size Share by Type (2021-2032) Figure 27. Research Institute Image Figure 28. Global Research Institute Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Hospital Image Figure 30. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Mesenchymal Stem Cells Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Mesenchymal Stem Cells Market Share by Application 2025 VS 2032 Figure 35. North America Mesenchymal Stem Cells Market Size Share by Application (2021-2032) Figure 36. Europe Mesenchymal Stem Cells Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Mesenchymal Stem Cells Market Size Share by Application (2021-2032) Figure 38. Latin America Mesenchymal Stem Cells Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Mesenchymal Stem Cells Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Mesenchymal Stem Cells Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Mesenchymal Stem Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Mesenchymal Stem Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Mesenchymal Stem Cells Market Share by Country (2021-2032) Figure 45. Europe Mesenchymal Stem Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Mesenchymal Stem Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Mesenchymal Stem Cells Market Share by Country (2021-2032) Figure 48. Asia-Pacific Mesenchymal Stem Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Mesenchymal Stem Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Mesenchymal Stem Cells Market Share by Country (2021-2032) Figure 51. Latin America Mesenchymal Stem Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Mesenchymal Stem Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Mesenchymal Stem Cells Market Share by Country (2021-2032) Figure 54. Middle East & Africa Mesenchymal Stem Cells Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Mesenchymal Stem Cells Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Mesenchymal Stem Cells Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Human MSC
  • Mouse MSC
  • Rat MSC
  • Others
Applications
  • Research Institute
  • Hospital
  • Others
Companies covered
  • Lonza
  • Thermo Fisher
  • Bio-Techne
  • ATCC
  • MilliporeSigma
  • PromoCell GmbH
  • Genlantis
  • Celprogen
  • Cell Applications
  • Cyagen Biosciences
  • Axol Bioscience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Mesenchymal Stem Cells Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Mesenchymal Stem Cells Market Size by Region (2021-2032)
  5. 1.4.1 Global Mesenchymal Stem Cells Market Size by Region (2021-2026)
  6. 1.4.2 Global Mesenchymal Stem Cells Market Size by Region (2027-2032)
  7. 1.5 Key Regions Mesenchymal Stem Cells Market Size (2021-2032)
  8. 1.5.1 North America Mesenchymal Stem Cells Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Mesenchymal Stem Cells Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Mesenchymal Stem Cells Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Mesenchymal Stem Cells Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Mesenchymal Stem Cells Market Size Growth Rate (2021-2032)
2 Mesenchymal Stem Cells Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Human MSC
  3. 2.1.2 Mouse MSC
  4. 2.1.3 Rat MSC
  5. 2.1.4 Others
  6. 2.2 Global Mesenchymal Stem Cells Market Size by Type
  7. 2.2.1 Global Mesenchymal Stem Cells Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Mesenchymal Stem Cells Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Mesenchymal Stem Cells Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Mesenchymal Stem Cells Market Size by Regions
  11. 2.3.1 North America Mesenchymal Stem Cells Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Mesenchymal Stem Cells Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Mesenchymal Stem Cells Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Mesenchymal Stem Cells Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Mesenchymal Stem Cells Market Size Breakdown by Type (2021-2026)
3 Mesenchymal Stem Cells Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Research Institute
  3. 3.1.2 Hospital
  4. 3.1.3 Others
  5. 3.2 Global Mesenchymal Stem Cells Market Size by Application
  6. 3.2.1 Global Mesenchymal Stem Cells Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Mesenchymal Stem Cells Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Mesenchymal Stem Cells Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Mesenchymal Stem Cells Market Size by Regions
  10. 3.3.1 North America Mesenchymal Stem Cells Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Mesenchymal Stem Cells Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Mesenchymal Stem Cells Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Mesenchymal Stem Cells Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Mesenchymal Stem Cells Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Mesenchymal Stem Cells Industry Trends
  2. 4.2 Mesenchymal Stem Cells Industry Drivers
  3. 4.3 Mesenchymal Stem Cells Industry Opportunities and Challenges
  4. 4.4 Mesenchymal Stem Cells Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Mesenchymal Stem Cells Revenue (2021-2026)
  2. 5.2 Global Mesenchymal Stem Cells Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Mesenchymal Stem Cells Key Company Headquarters & Area Served
  4. 5.4 Global Mesenchymal Stem Cells Company, Product Type & Application
  5. 5.5 Global Mesenchymal Stem Cells Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Mesenchymal Stem Cells Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Mesenchymal Stem Cells Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Mesenchymal Stem Cells Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Lonza
  2. 6.1.1 Lonza Company Information
  3. 6.1.2 Lonza Business Overview
  4. 6.1.3 Lonza Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Lonza Mesenchymal Stem Cells Product Portfolio
  6. 6.1.5 Lonza Recent Developments
  7. 6.2 Thermo Fisher
  8. 6.2.1 Thermo Fisher Company Information
  9. 6.2.2 Thermo Fisher Business Overview
  10. 6.2.3 Thermo Fisher Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Thermo Fisher Mesenchymal Stem Cells Product Portfolio
  12. 6.2.5 Thermo Fisher Recent Developments
  13. 6.3 Bio-Techne
  14. 6.3.1 Bio-Techne Company Information
  15. 6.3.2 Bio-Techne Business Overview
  16. 6.3.3 Bio-Techne Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Bio-Techne Mesenchymal Stem Cells Product Portfolio
  18. 6.3.5 Bio-Techne Recent Developments
  19. 6.4 ATCC
  20. 6.4.1 ATCC Company Information
  21. 6.4.2 ATCC Business Overview
  22. 6.4.3 ATCC Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 ATCC Mesenchymal Stem Cells Product Portfolio
  24. 6.4.5 ATCC Recent Developments
  25. 6.5 MilliporeSigma
  26. 6.5.1 MilliporeSigma Company Information
  27. 6.5.2 MilliporeSigma Business Overview
  28. 6.5.3 MilliporeSigma Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 MilliporeSigma Mesenchymal Stem Cells Product Portfolio
  30. 6.5.5 MilliporeSigma Recent Developments
  31. 6.6 PromoCell GmbH
  32. 6.6.1 PromoCell GmbH Company Information
  33. 6.6.2 PromoCell GmbH Business Overview
  34. 6.6.3 PromoCell GmbH Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 PromoCell GmbH Mesenchymal Stem Cells Product Portfolio
  36. 6.6.5 PromoCell GmbH Recent Developments
  37. 6.7 Genlantis
  38. 6.7.1 Genlantis Company Information
  39. 6.7.2 Genlantis Business Overview
  40. 6.7.3 Genlantis Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Genlantis Mesenchymal Stem Cells Product Portfolio
  42. 6.7.5 Genlantis Recent Developments
  43. 6.8 Celprogen
  44. 6.8.1 Celprogen Company Information
  45. 6.8.2 Celprogen Business Overview
  46. 6.8.3 Celprogen Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Celprogen Mesenchymal Stem Cells Product Portfolio
  48. 6.8.5 Celprogen Recent Developments
  49. 6.9 Cell Applications
  50. 6.9.1 Cell Applications Company Information
  51. 6.9.2 Cell Applications Business Overview
  52. 6.9.3 Cell Applications Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Cell Applications Mesenchymal Stem Cells Product Portfolio
  54. 6.9.5 Cell Applications Recent Developments
  55. 6.10 Cyagen Biosciences
  56. 6.10.1 Cyagen Biosciences Company Information
  57. 6.10.2 Cyagen Biosciences Business Overview
  58. 6.10.3 Cyagen Biosciences Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Cyagen Biosciences Mesenchymal Stem Cells Product Portfolio
  60. 6.10.5 Cyagen Biosciences Recent Developments
  61. 6.11 Axol Bioscience
  62. 6.11.1 Axol Bioscience Company Information
  63. 6.11.2 Axol Bioscience Business Overview
  64. 6.11.3 Axol Bioscience Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Axol Bioscience Mesenchymal Stem Cells Product Portfolio
  66. 6.11.5 Axol Bioscience Recent Developments
7 North America
  1. 7.1 North America Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Mesenchymal Stem Cells Market Size by Country (2021-2026)
  3. 7.3 North America Mesenchymal Stem Cells Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Mesenchymal Stem Cells Market Size by Country (2021-2026)
  3. 8.3 Europe Mesenchymal Stem Cells Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Mesenchymal Stem Cells Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Mesenchymal Stem Cells Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Mesenchymal Stem Cells Market Size by Country (2021-2026)
  3. 10.3 South America Mesenchymal Stem Cells Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Mesenchymal Stem Cells Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst